1.
Ernst T, Hoffmann J, Erben P, Hanfstein B, Leitner A, Hehlmann R, Hochhaus A, Müller MC. ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia. Haematologica [Internet]. 2008Aug.29 [cited 2026Nov.16];93(9):1389-93. Available from: https://haematologica.org/article/view/5001